Dr. Raymond F. Schinazi, PhD, Hon DSc, FAASLD, is the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University. Dr. Schinazi holds a PhD in Chemistry from the University of Bath, England (1976). Dr. Schinazi has been with Emory University since 1978. Dr. Schinazi has authored over 600 peer-reviewed papers and 7 books. He holds over 100 issued US patents, which have resulted in 28 New Drug Applications (NDA). A world leader in nucleoside chemistry, Dr. Schinazi is best known for his pioneering work on HIV, HBV and HCV drugs including FTC (emtricitabine), LdT (telbivudine), and sofosbuvir (Sovaldi). More than 94% of HIV-infected individuals in the US on combination therapy take at least one of the drugs he invented. He is also the inventor of the use of baricitimid a JAK inhibitor for the treatment of COVID-19 patients. Dr. Schinazi is a Charter Fellow of the National Academy of Inventors. He is the recipient of numerous awards, including: 2018 France’s highest civilian honor, the Légion D’honneur, for saving millions of lives globally. In 2020, he became Fellow of the American Association for the Advancement of Science (AAAS), and in 2021, he received the AASLD Distinguished Achievement Award. Dr. Schinazi is internationally recognized as one of the most influential persons in the life science sector.